COVID-19 Archives - Page 4 of 6

Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions

Sarah L Anderson, Matteo Bassetti, Arduino A Mangoni

Article Type

Editorial

Published

22 Jan 2021

The Senior Editors of Drugs in Context provide us with their expert opinion on the events of 2020 and what lies ahead in 2021.

Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL* protocol

Teodoro Iturbe-Hernandez MD, Luis García de Guadiana Romualdo MD, Ignacio Gil Ortega MD, Antonio Martínez Francés MD, Olga Meca Birlanga MD, Juan José Cerezo-Manchado MD

Article Type

Original Research

Published

18 Sep 2020

In this review, the available information on the antithrombotic management of atrial fibrillation patients at discharge after COVID-19 infection is updated. In addition, a practical algorithm, considering renal and liver function, which facilitates the anticoagulation choice at discharge is presented.

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus

Alexander KC Leung MBBS, FRCP (UK & Irel), FRCPCH, FAAP, Tara McMillan MD, FRCPC, Andrea Human MD, FRCPC, Joseph M Lam MD, FRCPC

Article Type

Case Report

Published

20 Jul 2020

Physicians who use hydroxychloroquine in children should be aware of this less-known side effect of hydroxychloroquine so that an accurate diagnosis can be made, and unnecessary investigations and inappropriate treatment can be avoided.

Kawasaki disease in siblings and a review of drug treatment

Steven King-fan Loo MBChB, FRCP, Kam Lun Hon MBBS, MD, FAAP, FCCM, Alexander KC Leung MBBS, FRCPC, FRCP (UK & Irel), FRCPCH, FAAP, Tak Cheung Yung MBBS, MRCPCH, Man Ching Yam MBChB, MRCPCH

Article Type

Case Report

Published

07 Jul 2020

This article describes the management of two siblings with KD
followed by a short review.

Coronavirus disease 2019 (COVID-19): latest developments in potential treatments

Kam Lun Hon MBBS, MD, Karen Ka Yan Leung MBBS, MRCPCH, Alexander KC Leung MBBS, FRCPC, FRCP (UK & Irel), FRCPCH, FAAP, Su Yun Qian MD, Vivian PY Chan MPharm, MSc (Clin Pharm), BPharm, BCPPS, BCNSP, Patrick Ip MBBS, FRCPCH (Hon), FRCPCH, Ian CK Wong BPharm (Hons), MSc, PhD, FRCPCH (Hon)

Article Type

Review

Published

29 Jun 2020

This overview aims to review the current developments in preventive treatments and therapies for COVID-19.